MedTrace Logo

Lipids and Neurological Complications in Liver Transplantation

NCT02544919 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-03-27

No results posted yet for this study

Summary

To study the impact of pretreatment of living donor liver transplantation recipients with SMOF lipid on the incidence and severity of post-transplantation neurological complications in patients receiving tacrolimus based immunosuppression protocol

Conditions

  • Neurological Complications

Interventions

DRUG

SMOF lipid (SMOFLIPID) pre treatment

Experimental Arm

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Amr M Yassen, MD · MAnsoura Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-09-30
Completion
2017-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02544919 on ClinicalTrials.gov